Henry Schein price target raised to $64 from $61 at Morgan Stanley

Morgan Stanley analyst Erin Wright raised the firm’s price target on Henry Schein (HSIC) to $64 from $61 and keeps an Underweight rating on the shares. The firm’s U.S. dental survey suggests softer practice volume across Q1, but the Specialty segment, including clear aligner and implant, demand improved slightly, the analyst tells investors.